Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and female outpatients~* Aged 6 to 59 months~* Body weight between 7.5 to 30 kg~* uncomplicated falciparum malaria with parasitaemia between 1,000/µL and 200,000/µL~* Ability to tolerate oral therapy~* Informed consent, oral agreement of the child if appropriate~Exclusion Criteria:~* Still in IPTi trial and/or still in any other intervention trial~* Known G6PD-deficiency~* Presence of severe malnutrition~* Inability to drink or breastfeed~* Recent history of convulsions, lethargy or unconsciousness;~* Signs of severe and complicated~* Mixed/mono infection that includes a non-P. falciparum species.~* Hb \< 7g/dl~* Inability to attend stipulated follow-up visits.~* History of hypersensitivity reactions to the drug being evaluated

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 59 Months
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).